Highlights:
- Expelling bottlenecks key to enhancing stroke pathways of care
- William Mack: Neuroprotection
- Profile: Tommy Andersson
- Neuromodulation section
- ASRA calls for reconsideration of “experimental” labelling for HF10 therapy
[pdfviewer width=”100%” height=”940px” beta=”true”]https://neuronewsinternational.com/wp-content/uploads/sites/3/2016/10/23-NeuroNews-EU.pdf[/pdfviewer]
